Work

Efficacy of rezafungin in a case of Candida spondylodiskitis

Year: 2024

Type: article

Abstract: Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of Candida glabrata spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.

Source: Journal of Bone and Joint Infection

DOI: 10.5194/jbji-9-213-2024

Authors: Marin Lahouati, Claire Tinévez, Frédéric Gabriel, Fabien Xuereb, Maxime Lefranc, Frédéric-Antoine Dauchy

Institutions: Université de Bordeaux, Inserm, Centre Hospitalier Universitaire de Bordeaux, Biologie des maladies cardiovasculaires

Language: English

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,078